P-glycoprotein and its inhibition in tumors by phytochemicals derived from Chinese herbs

Abidi, 2006, The medicinal plant goldenseal is a natural LDL-lowering agent with multiple bioactive components and new action mechanisms, Journal of Lipid Research, 47, 2134, 10.1194/jlr.M600195-JLR200 Adams, 2007, Cytotoxicity and p-glycoprotein modulating effects of quinolones and indoloquinazolines from the Chinese herb Evodia rutaecarpa, Planta Medica, 73, 1554, 10.1055/s-2007-993743 Adams, 2007, In vitro cytotoxicity and P-glycoprotein modulating effects of geranylated furocoumarins from Tetradium daniellii, Planta Medica, 73, 1475, 10.1055/s-2007-990261 Ameyaw, 2001, MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity, Pharmacogenetics, 11, 217, 10.1097/00008571-200104000-00005 Ampasavate, 2010, Effects of Curcuma spp. on P-glycoprotein function, Phytomedicine, 17, 506, 10.1016/j.phymed.2009.09.004 Angelini, 2010, Modulation of multidrug resistance p-glycoprotein activity by flavonoids and honokiol in human doxorubicin-resistant sarcoma cells (MES-SA/DX-5): implications for natural sedatives as chemosensitizing agents in cancer therapy, Journal of Biological Regulators and Homeostatic Agents, 24, 197 Aran, 1999, Therapeutic strategies involving the multidrug resistance phenotype: the MDR1 gene as target, chemoprotectant, and selectable marker in gene therapy, Advances in Pharmacology, 46, 1, 10.1016/S1054-3589(08)60468-8 Ayesh, 1996, Co-operative, competitive and non-competitive interactions between modulators of P-glycoprotein, Biochimica et Biophysica Acta, 1316, 8, 10.1016/0925-4439(96)00008-7 Baer, 2002, Phase 3 study of the multidrug-resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720, Blood, 100, 1224, 10.1182/blood.V100.4.1224.h81602001224_1224_1232 Bansal, 2008, Pre-clinical evidence for altered absorption and biliary excretion of irinotecan (CPT-11) in combination with quercetin: possible contribution of P-glycoprotein, Life Sciences, 83, 250, 10.1016/j.lfs.2008.06.007 Bertram, 1995, Reversal of multiple drug resistance in vitro by phosphorothioate oligonucleotides and ribozymes, Anti-Cancer Drugs, 6, 124, 10.1097/00001813-199502000-00015 Biermann, 1993, High dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin's disease: long-term follow-up in 128 patients, Annals of Oncology: Official Journal of the European Society of Medical Oncology/ESMO, 4, 767, 10.1093/oxfordjournals.annonc.a058662 Bolhuis, 1996, Multidrug resistance in Lactococcus lactis: evidence for ATP-dependent drug extrusion from the inner leaflet of the cytoplasmic membrane, The EMBO Journal, 15, 4239, 10.1002/j.1460-2075.1996.tb00798.x Borgnia, 1996, Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity, Journal of Biological Chemistry, 271, 3163, 10.1074/jbc.271.6.3163 Botstein, 2003, Discovering genotypes underlying human phenotypes: past successes for Mendelian disease, future approaches for complex disease, Nature Genetics, 33, 228, 10.1038/ng1090 Calcabrini, 2004, Terpinen-4-ol, the main component of Melaleuca alternifolia (tea tree) oil inhibits the in vitro growth of human melanoma cells, The Journal of Investigative Dermatology, 122, 349, 10.1046/j.0022-202X.2004.22236.x Cao, 2007, Role of P-glycoprotein in the intestinal absorption of glabridin, an active flavonoid from the root of Glycyrrhiza glabra, Drug Metabolism and Disposition, 35, 539, 10.1124/dmd.106.010801 Carlson, 2003, Additional SNPs and linkage-disequilibrium analyses are necessary for whole-genome studies in humans, Nature Genetics, 33, 518, 10.1038/ng1128 Carr, 1987, Pleiotropic drug resistance in hepatocytes induced by carcinogens administered to rats, Cancer Research, 47, 5577 Chai, 2010, Circumvention of multi-drug resistance of cancer cells by Chinese herbal medicines, Chinese Medicine, 5, 26, 10.1186/1749-8546-5-26 Chan, 1991, P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma, The New England Journal of Medicine, 325, 1608, 10.1056/NEJM199112053252304 Chan, 2006, The effects of sinomenine on intestinal absorption of paeoniflorin by the everted rat gut sac model, Journal of Ethnopharmacology, 103, 425, 10.1016/j.jep.2005.08.020 Chang, 2004, Salvinal, a novel microtubule inhibitor isolated from Salvia miltiorrhizae Bunge (Danshen), with antimitotic activity in multidrug-sensitive and -resistant human tumor cells, Molecular Pharmacology, 65, 77, 10.1124/mol.65.1.77 Chen, 1986, Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells, Cell, 47, 381, 10.1016/0092-8674(86)90595-7 Chen, 2002, Marked decrease of cyclosporin absorption caused by phellamurin in rats, Planta Medica, 68, 138, 10.1055/s-2002-20244 Chen, 2008, Characterization of the transportation of berberine in Coptidis rhizoma extract through rat primary cultured cortical neurons, Biomedical Chromatography, 22, 28, 10.1002/bmc.889 Chen, 2010, Triptolide circumvents drug-resistant effect and enhances 5-fluorouracil antitumor effect on KB cells, Anticancer Drugs, 21, 502, 10.1097/CAD.0b013e328337337c Choi, 2003, Reversal of P-glycoprotein-mediated multidrug resistance by protopanaxatriol ginsenosides from Korean red ginseng, Planta Medica, 69, 235, 10.1055/s-2003-38483 Choi, 1988, An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene, Cell, 53, 519, 10.1016/0092-8674(88)90568-5 Choi, 1998, The bisbenzylisoquinoline alkaloids, tetrandine and fangchinoline, enhance the cytotoxicity of multidrug resistance-related drugs via modulation of P-glycoprotein, Anticancer Drugs, 9, 255, 10.1097/00001813-199803000-00008 Cordon-Cardo, 1989, Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood–brain barrier sites, Proceedings of the National Academy of Sciences of the United States of America, 86, 695, 10.1073/pnas.86.2.695 Dai, 2008, Transport and metabolism of flavonoids from Chinese herbal remedy Xiaochaihu-tang across human intestinal Caco-2 cell monolayers, Acta Pharmacologica Sinica, 29, 1086, 10.1111/j.1745-7254.2008.00850.x Dalton, 1995, A phase II randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A Southwest Oncology Group study, Cancer, 75, 815, 10.1002/1097-0142(19950201)75:3<815::AID-CNCR2820750311>3.0.CO;2-R Dong, 2009, Absorption of extractive Radix Paeoniae Alba in rat everted gut sacs and its interaction with P-glycoprotein, Zhongguo Zhong Yao Za Zhi, 34, 884 Dönmez, 2011, Reversal of multidrug resistance by small interfering RNA (siRNA) in doxorubicin-resistant MCF-7 breast cancer cells, Biomedicine and Pharmacotherapy, 65, 85, 10.1016/j.biopha.2010.12.007 Eckert, 1996, High-dose multidrug resistance in primary human hematopoietic progenitor cells transduced with optimized retroviral vectors, Blood, 88, 3407, 10.1182/blood.V88.9.3407.bloodjournal8893407 Efferth, 2002, Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells, Blood Cells, Molecules and Diseases, 28, 160, 10.1006/bcmd.2002.0492 Efferth, 1993, Reversal of inherent multidrug-resistance in primary human renal cell carcinoma cell cultures by S 9788, Anticancer Research, 13, 905 Efferth, 1996, Anti-Fas/Apo-1 monoclonal antibody CH-11 depletes glutathione and kills multidrug-resistant human leukemic cells, Blood Cells, Molecules and Diseases, 22, 2, 10.1006/bcmd.1996.0002 Efferth, 2007, Molecular target-guided tumor therapy with natural products derived from traditional Chinese medicine, Current Medicinal Chemistry, 14, 2024, 10.2174/092986707781368441 Efferth, 2001, 5-Azacytidine modulates the response of sensitive and multidrug-resistant K562 leukemic cells to cytostatic drugs, Blood Cells, Molecules and Diseases, 27, 637, 10.1006/bcmd.2001.0427 Efferth, 2000, Impact of viral oncogenesis on responses to anti-cancer drugs and irradiation, Critical Reviews in Oncogenesis, 11, 165 Efferth, 2008, Phytochemistry and pharmacogenomics of natural products derived from traditional Chinese medicine and Chinese materia medica with activity against tumor cells, Molecular Cancer Therapeutics, 7, 152, 10.1158/1535-7163.MCT-07-0073 Efferth, 1991, Reversing multidrug resistance in L1210 tumor cells by hycanthone or chlorophenoxamine in vitro and in vivo, Anticancer Research, 11, 1275 Efferth, 2008, Prediction of broad spectrum resistance of tumors towards anticancer drugs, Clinical Cancer Research, 14, 2405, 10.1158/1078-0432.CCR-07-4525 Efferth, 1991, Selective growth-inhibition of multidrug-resistant CHO-cells by the monoclonal antibody 265/F4, British Journal of Cancer, 64, 87, 10.1038/bjc.1991.245 Efferth, 2007, From traditional Chinese medicine to rational cancer therapy, Trends in Molecular Medicine, 13, 353, 10.1016/j.molmed.2007.07.001 Efferth, 1992, Immunohistochemical detection of P glycoprotein, glutathione S transferase and DNA topoisomerase II in human tumors, Oncology, 49, 368, 10.1159/000227075 Efferth, 2007, Pharmacogenomics of a traditional Japanese herbal medicine (Kampo) for cancer therapy, Cancer Genomics and Proteomics, 4, 81 Efferth, 1993, Clinical relevance of the MDR-1 gene and its gene-product. P-glycoprotein, for cancer chemotherapy: a meta-analysis, Tumordiagnostik und Therapie, 14, 238 Efferth, 2003, Analysis of single nucleotide polymorphism C3435T of the multidrug resistance gene MDR1 in acute lymphoblastic leukemia, International Journal of Oncology, 23, 509 Efferth, 1992, Antibody-directed therapy of multidrug-resistant tumor cells, Medical Oncology and Tumor Pharmacotherapy, 9, 11, 10.1007/BF02989648 Efferth, 1993, Modulation of P-glycoprotein-mediated multidrug resistance by monoclonal antibodies, immunotoxins or antisense oligodeoxynucleotides in kidney carcinoma and normal kidney cells, Oncology, 50, 303, 10.1159/000227200 Efferth, 1993, Reversal of doxorubicin-resistance in sarcoma 180 tumor cells by inhibition of different resistance mechanisms, Cancer Letters, 70, 197, 10.1016/0304-3835(93)90231-W Efferth, 2005, Pharmacogenetics for individualized cancer chemotherapy, Pharmacology and Therapeutics, 107, 155, 10.1016/j.pharmthera.2005.02.005 Eichelbaum, 2004, Clinical aspects of the MDR1 (ABCB1) gene polymorphism, Therapeutic Drug Monitoring, 26, 180, 10.1097/00007691-200404000-00017 Eswar, 2006, Comparative protein structure modeling with MODELLER Evans, 1999, Pharmacogenomics: translating functional genomics into rational therapeutics, Science, 286, 487, 10.1126/science.286.5439.487 Fairchild, 1987, Carcinogen-induced mdr overexpression is associated with xenobiotic resistance in rat preneoplastic liver nodules and hepatocellular carcinomas, Proceedings of the National Academy of Sciences of the United States of America, 84, 7701, 10.1073/pnas.84.21.7701 Fan, 2009, Effect of Schisandra chinensis extract and Ginkgo biloba extract on the pharmacokinetics of talinolol in healthy volunteers, Xenobiotica, 39, 249, 10.1080/00498250802687657 Fan, 2009, Effects of Ginkgo biloba extract ingestion on the pharmacokinetics of talinolol in healthy Chinese volunteers, The Annals of Pharmacotherapy, 43, 944, 10.1345/aph.1L656 Farabegoli, 2010, (−)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line, Phytomedicine, 17, 356, 10.1016/j.phymed.2010.01.001 Fellner, 2002, Transport of paclitaxel (Taxol) across the blood–brain barrier in vitro and in vivo, Journal of Clinical Investigation, 110, 1309, 10.1172/JCI0215451 Fischer, 1998, The multidrug resistance modulator valspodar (PSC 833) is metabolized by human cytochrome P450 3A. Implications for drug–drug interactions and pharmacological activity of the main metabolite, Drug Metabolism and Disposition, 26, 802 FitzGerald, 1987, A monoclonal antibody-Pseudomonas toxin conjugate that specifically kills multidrug-resistant cells, Proceedings of the National Academy of Sciences of the United States of America, 84, 4288, 10.1073/pnas.84.12.4288 Fojo, 1987, Expression of a multidrug-resistance gene in human tumors and tissues, Proceedings of the National Academy of Sciences of the United States of America, 84, 265, 10.1073/pnas.84.1.265 Fong, 2007, Schisandrol A from Schisandra chinensis reverses P-glycoprotein-mediated multidrug resistance by affecting Pgp-substrate complexes, Planta Medica, 73, 212, 10.1055/s-2007-967120 Fong, 2007, Reversal of multidrug resistance in cancer cells by Rhizoma Alismatis extract, Phytomedicine, 14, 160, 10.1016/j.phymed.2006.03.004 Ford, 1993, Pharmacologic circumvention of multidrug resistance, Cytotechnology, 12, 171, 10.1007/BF00744664 Ford, 1996, P-Glycoprotein-mediated multidrug resistance: experimental and clinical strategies for its reversal, Cancer Treatment and Research, 87, 3, 10.1007/978-1-4613-1267-3_1 Fracasso, 2004, Phase I study of docetaxel in combination with the P-glycoprotein inhibitor, zosuquidar, in resistant malignancies, Clinical Cancer Research, 10, 7220, 10.1158/1078-0432.CCR-04-0452 Fu, 2003, Experimental chemotherapy against xenografts derived from multidrug resistant KBv200 cells and parental drug-sensitive KB cells in nude mice by annonaceous acetogenin 89-2, Yao Xue Xue Bao, 38, 565 Gao, 2008, Effects of some traditional Chinese drugs on Mdr1 gene and its expression product in K562/A02 cells, Zhongguo Shi Yan Xue Ye Xue Za Zhi, 16, 785 Geng, 2008, Coriaria lactone induces in vitro the overexpression of multidrug resistance P-glycoprotein in astrocyte from rat brain, Sichuan Da Xue Xue Bao Yi Xue Ban, 39, 80 Germann, 1996, P-glycoprotein—a mediator of multidrug resistance in tumour cells, European Journal of Cancer, 32A, 927, 10.1016/0959-8049(96)00057-3 Gillet, 2007, Chemotherapy-induced resistance by ATP-binding cassette transporter genes, Biochimica and Biophysica Acta Review Cancer, 1775, 237, 10.1016/j.bbcan.2007.05.002 Globisch, 2008, Identification of putative binding sites of P-glycoprotein based on its homology model, Chemical Medicinal Chemistry, 3, 280, 10.1002/cmdc.200700249 Goh, 2002, Explaining interindividual variability of docetaxel pharmacokinetics and pharmacodynamics in Asians through phenotyping and genotyping strategies, Journal of Clinical Oncology, 20, 3683, 10.1200/JCO.2002.01.025 Gotoh, 2004, Antiproliferative activity of Rhinacanthus nasutus (L.) Kurz extracts and the active moiety, Rhinacanthin C, Biological & Pharmaceutical Bulletin, 27, 1070, 10.1248/bpb.27.1070 Gottesman, 1995, Genetic analysis of the multidrug transporter, Annual Review of Genetics, 29, 607, 10.1146/annurev.ge.29.120195.003135 Gottesman, 1993, Biochemistry of multidrug resistance mediated by the multidrug transporter, Annual Review of Biochemistry, 62, 385, 10.1146/annurev.bi.62.070193.002125 Gu, 2004, Transport and bioavailability studies of astragaloside IV, an active ingredient in Radix Astragali, Basic and Clinical Pharmacology and Toxicology, 95, 295, 10.1111/j.1742-7843.2004.t01-1-pto950508.x Hall, 2009, Is resistance useless? Multidrug resistance and collateral sensitivity, Trends in Pharmacological Sciences, 30, 546, 10.1016/j.tips.2009.07.003 He, 2002, Effects of various principles from Chinese herbal medicine on rhodamine123 accumulation in brain capillary endothelial cells, Acta Pharmacologica Sinica, 23, 591 He, 2010, Transmembrane transport activity of paclitaxel regulated by fangchinoline in MDR1-mDCK II cells, Zhongguo Zhong Yao Za Zhi, 35, 1478 He, 2009, Inhibition of P-glycoprotein function by procyanidine on blood–brain barrier, Phytotherapy Research, 23, 933, 10.1002/ptr.2781 Higgins, 1992, Is the multidrug transporter a flippase?, Trends in Biochemical Sciences, 17, 18, 10.1016/0968-0004(92)90419-A Hill, 1990, Overexpression of P-glycoprotein in mammalian tumor cell lines after fractionated X irradiation in vitro, Journal of the National Cancer Institute, 82, 607, 10.1093/jnci/82.7.607 Ho, 1996, Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide libraries, Nucleic Acids Research, 24, 1901, 10.1093/nar/24.10.1901 Hoffmeyer, 2000, Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo, Proceedings of the National Academy of Sciences of the United States of America, 97, 3473, 10.1073/pnas.050585397 Holland, 1980, Adverse effect of radiotherapy on adjuvant chemotherapy for carcinoma of the breast, Surgery Gynecology and Obstetrics, 150, 817 Holm, 1994, Reversion of multidrug resistance in the P-glycoprotein-positive human pancreatic cell line (EPP85-181RDB) by introduction of a hammerhead ribozyme, British Journal of Cancer, 70, 239, 10.1038/bjc.1994.286 Holmes, 1994, The effect of MDR-1 gene expression on outcome in acute myeloblastic leukaemia, British Journal of Cancer, 69, 382, 10.1038/bjc.1994.70 Honda, 2002, Polymorphism of MDR1 gene in healthy Japanese subjects: a novel SNP with an amino acid substitution (Glu108Lys), Drug Metabolism and Pharmacokinetics, 17, 479, 10.2133/dmpk.17.479 Hu, 2008, Tenacigenin B derivatives reverse P-glycoprotein-mediated multidrug resistance inHepG2/Dox cells, Journal of Natural Products, 71, 1049, 10.1021/np070458f Huang, 2008, Effect of Glycyrrhiza inflata and Daphne genkwa on permeabilities of rhodamine 123, a P-glycoprotein substrate across rat jejunum membranes in vitro, Zhongguo Zhong Yao Za Zhi, 33, 2521 Huang, 2008, Reversal of P-glycoprotein-mediated multidrug resistance of cancer cells by five schizandrins isolated from the Chinese herb Fructus Schizandrae, Cancer Chemotherapy and Pharmacology, 62, 1015, 10.1007/s00280-008-0691-0 Huang, 2010, Studies on reversing MDR of K562/A02 by ramification of curcumin hydrolyzed, Zhongguo Zhong Yao Za Zhi, 35, 2460 Humeny, 2003, MDR1 single nucleotide polymorphism C3435T in normal colorectal tissue and colorectal carcinomas detected by MALDI-TOF mass spectrometry, Anticancer Research, 23, 2735 Illmer, 2002, MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients, Cancer Research, 62, 4955 Juliano, 1976, A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants, Biochimica and Biophysica Acta, 455, 152, 10.1016/0005-2736(76)90160-7 Kamp, 1998, Evidence for a role of the multidrug resistance protein (MRP) in the outward translocation of NBD-phospholipids in the erythrocyte membrane, Biochimica et Biophysica Acta, 1372, 91, 10.1016/S0005-2736(98)00049-2 Keith, 1991, Carcinogenesis and the response of tumours to anticancer drugs, Anticancer Research, 11, 1739 Kim, 2002, MDR1 single nucleotide polymorphisms: multiplicity of haplotypes and functional consequences, Pharmacogenetics, 12, 425, 10.1097/00008571-200208000-00002 Kim, 1998, The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors, Journal of Clinical Investigation, 101, 289, 10.1172/JCI1269 Kitagawa, 2004, Inhibition of P-glycoprotein function by tea catechins in KB-C2 cells, The Journal of Pharmacy and Pharmacology, 56, 1001, 10.1211/0022357044003 Kruijtzer, 2002, Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918, Journal of Clinical Oncology, 20, 2943, 10.1200/JCO.2002.12.116 Kurata, 2002, Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoprotein, Clinical Pharmacology and Therapeutics, 72, 209, 10.1067/mcp.2002.126177 Lan, 2008, Intra-herb pharmacokinetics interaction between quercetin and isorhamentin, Acta Pharmacologica Sinica, 29, 1376, 10.1111/j.1745-7254.2008.00884.x LeBlanc, 2003, Effects of dietary soybean lecithin on plasma lipid transport and hepatic cholesterol metabolism in rats, The Journal of Nutritional Biochemistry, 14, 40, 10.1016/S0955-2863(02)00253-X Lee, 1998, HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter, Biochemistry, 37, 3594, 10.1021/bi972709x Lee, 2004, Increased anti-P-glycoprotein activity of baicalein by alkylation on the A ring, Journal of Medicinal Chemistry, 47, 5555, 10.1021/jm049949c Leung, 2006, Intestinal absorption of Stemona alkaloids in a Caco-2 cell model, Planta Medica, 72, 211, 10.1055/s-2005-916195 Li, 2005, The effect of tetrandrine on the expression of the P170, LRP and TOPO II in S180s tumor cell induced by chemotherapy in the mice with acquired multi-drug resistance, Zhongguo Zhong Yao Za Zhi, 30, 1280 Li, 2007, Effect on mouse S180 MDR tumour cell expression correlated factorial matter by 70% ethanol with Huanglian Jiedu Tang, Zhongguo Zhong Yao Za Zhi, 32, 1906 Li, 2009, Bioactive terpenoids and flavonoids from Ginkgo biloba extract induce the expression of hepatic drug-metabolizing enzymes through pregnane X receptor, constitutive androstane receptor, and aryl hydrocarbon receptor-mediated pathways, Pharmaceutical Research, 26, 872, 10.1007/s11095-008-9788-8 Li, 2009, The augmented anti-tumor effects of Antrodia camphorata co-fermented with Chinese medicinal herb in human hepatoma cells, The American Journal of Chinese Medicine, 37, 771, 10.1142/S0192415X09007235 Li, 2010, Induction of CYP3A4 and MDR1 gene expression by baicalin, baicalein, chlorogenic acid, and ginsenoside Rf through constitutive androstane receptor- and pregnane X receptor-mediated pathways, European Journal of Pharmacology, 640, 46, 10.1016/j.ejphar.2010.05.017 Liang, 2010, Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer, International Journal of Oncology, 37, 111 Lin, 1999, Up-regulation of multidrug resistance transporter expression by berberine in human and murine hepatoma cells, Cancer, 85, 1937, 10.1002/(SICI)1097-0142(19990501)85:9%3C1937::AID-CNCR9%3E3.0.CO;2-F Lin, 1999, Berberine modulates expression of mdr1 gene product and the responses of digestive track cancer cells to Paclitaxel, British Journal of Cancer, 81, 416, 10.1038/sj.bjc.6690710 Madgula, 2008, Transport of Schisandra chinensis extract and its biologically-active constituents across Caco-2 cell monolayers—an in-vitro model of intestinal transport, Journal of Pharmaceutical Pharmacology, 60, 363, 10.1211/jpp.60.3.0012 Mahringer, 2010, Inhibition of P-glycoprotein at the blood–brain barrier by phytochemicals derived from traditional Chinese medicine, Cancer Genomics Proteomics, 7, 191 Majumder, 2006, Reversal of drug resistance in P-glycoprotein-expressing T-cell acute lymphoblastic CEM leukemia cells by copper N-(2-hydroxy acetophenone) glycinate and oxalyl bis (N-phenyl) hydroxamic acid, Cancer Letters, 244, 16, 10.1016/j.canlet.2005.11.030 Mei, 2004, Reversal of cancer multidrug resistance by green tea polyphenols, The Journal of Pharmacy and Pharmacology, 56, 1307, 10.1211/0022357044364 Mickley, 1997, Gene rearrangement: a novel mechanism for MDR-1 gene activation, The Journal of Clinical Investigation, 99, 1947, 10.1172/JCI119362 Min, 2006, Protoberberine alkaloids and their reversal activity of P-gp expressed multidrug resistance (MDR) from the rhizome of Coptis japonica Makino, Archives of Pharmacal Research, 29, 757, 10.1007/BF02974076 Molnár, 2010, Reversal of multidrug resistance by natural substances from plants, Current Topics in Medicinal Chemistry, 10, 1757, 10.2174/156802610792928103 Mukai, 2009, Inhibition of P-glycoprotein enhances the suppressive effect of kaempferol on transformation of the aryl hydrocarbon receptor, Bioscience, Biotechnology, and Biochemistry, 73, 1635, 10.1271/bbb.90145 Nakayama, 1998, Hypomethylation status of CpG sites at the promoter region and overexpression of the human MDR1 gene in acute myeloid leukemias, Blood, 92, 4296, 10.1182/blood.V92.11.4296 Newman, 2007, Natural products as sources of new drugs over the last 25 years, Journal of Natural Products, 70, 461, 10.1021/np068054v Nishimura, 2005, Effects of Chinese herbal medicines on intestinal drug absorption, Yakugaku Zasshi, 125, 363, 10.1248/yakushi.125.363 Nobili, 2006, Pharmacological strategies for overcoming multidrug resistance, Current Drug Targets, 7, 861, 10.2174/138945006777709593 Osmak, 1989, Multiple fractions of gamma rays induced resistance to cis-dichloro-diammineplatinum (II) and methotrexate in human HeLa cells, International Journal of Oncology, Biology, Physics, 16, 1537, 10.1016/0360-3016(89)90959-0 Plasschaert, 2004, Influence of functional polymorphisms of the MDR1 gene on vincristine pharmacokinetics in childhood acute lymphoblastic leukemia, Clinical Pharmacology and Therapeutics, 76, 220, 10.1016/j.clpt.2004.05.007 Podda, 1992, Transfer and expression of the human multiple drug resistance gene into live mice, Proceedings of the National Academy of Sciences of the United States of America, 89, 9676, 10.1073/pnas.89.20.9676 Qin, 2010, Mechanistic understanding of the different effects of Wuzhi Tablet (Schisandra sphenanthera extract) on the absorption and first-pass intestinal and hepatic metabolism of Tacrolimus (FK506), International Journal of Pharmaceutics, 389, 114, 10.1016/j.ijpharm.2010.01.025 Qiu, 2009, Effect of berberine on the pharmacokinetics of substrates of CYP3A and P-gp, Phytotherapy Research, 23, 1553, 10.1002/ptr.2808 Ramu, 1989, Doxorubicin resistance in P388 leukemia—evidence for reduced drug influx, International Journal of Cancer, 44, 539, 10.1002/ijc.2910440328 Rautio, 2006, In vitro P-glycoprotein inhibition assays for assessment of clinical drug interaction potential of new drug candidates: a recommendation for probe substrates, Drug Metabolism and Disposition, 34, 786, 10.1124/dmd.105.008615 Raviv, 1990, Photosensitized labeling of a functional multidrug transporter in living drug-resistant tumor cells, The Journal of Biological Chemistry, 265, 3975, 10.1016/S0021-9258(19)39690-5 Rhoads, 1947, Report on a cooperative study of nitrogen mustard (HN2) therapy of neoplastic disease, Transactions of the Association of American Physicians, 60, 110 Risch, 2001, The genetic epidemiology of cancer: interpreting family and twin studies and their implications for molecular genetic approaches, Cancer Epidemiology, Biomarkers and Prevention, 10, 733 Roepe, 1995, The role of the MDR protein in altered drug translocation across tumor cell membranes, Biochimica et Biophysica Acta, 1241, 385, 10.1016/0304-4157(95)00013-5 Roninson, 1986, Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells, Proceedings of the National Academy of Sciences of the United States of America, 83, 4538, 10.1073/pnas.83.12.4538 Ruetz, 1994, A mechanism for P-glycoprotein action in multidrug resistance: are we there yet?, Trends in Pharmacological Sciences, 15, 260, 10.1016/0165-6147(94)90322-0 Ruiz, 1989, Autonomously replicating episomes contain mdr1 genes in a multidrug-resistant human cell line, Molecular Cell Biology, 9, 109, 10.1128/MCB.9.1.109 Sachidanandam, 2001, A map of human genome sequence variations 1.42 million single nucleotide polymorphisms, Nature, 409, 928, 10.1038/35057149 Safa, 2004, Identification and characterization of the binding sites of P-glycoprotein for multidrug resistance-related drugs and modulators, Current Medicinal Chemistry Anticancer Agents, 4, 1, 10.2174/1568011043482142 Sakaeda, 2001, MDR1 genotype-related pharmacokinetics of digoxin after single oral administration in healthy Japanese subjects, Pharmaceutical Research, 18, 1400, 10.1023/A:1012244520615 Sakaeda, 2003, Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs, Pharmacogenomics, 4, 397, 10.1517/phgs.4.4.397.22747 Sauerbrey, 1994, P-glycoprotein and glutathione S-transferase pi in childhood acute lymphoblastic leukaemia, British Journal of Cancer, 70, 1144, 10.1038/bjc.1994.462 Scaggiante, 1994, Effect of unmodified triple helix-forming oligodeoxyribonucleotide targeted to human multidrug-resistance gene mdr1 in MDR cancer cells, FEBS Letters, 352, 380, 10.1016/0014-5793(94)00995-3 Schinkel, 2003, Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview, Advanced Drug Delivery Reviews, 55, 3, 10.1016/S0169-409X(02)00169-2 Schinkel, 1997, Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins, Proceedings of the National Academy of Sciences of the United States of America, 94, 4028, 10.1073/pnas.94.8.4028 Schinkel, 1994, Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood–brain barrier and to increased sensitivity to drugs, Cell, 77, 491, 10.1016/0092-8674(94)90212-7 Schinkel, 1996, P-glycoprotein in the blood–brain barrier of mice influences the brain penetration and pharmacological activity of many drugs, The Journal of Clinical Investigation, 97, 2517, 10.1172/JCI118699 Schneider, 1989, P-glycoprotein expression in treated and untreated human breast cancer, British Journal of Cancer, 60, 815, 10.1038/bjc.1989.372 Schwab, 2003, Genetic polymorphisms of the human MDR1 drug transporter, Annual Review of Pharmacology and Toxicology, 43, 285, 10.1146/annurev.pharmtox.43.100901.140233 Seelig, 1998, A general pattern for substrate recognition by P-glycoprotein, European Journal of Biochemistry, 251, 252, 10.1046/j.1432-1327.1998.2510252.x Seelig, 2000, Structure–activity relationship of P-glycoprotein substrates and modifiers, European Journal of Pharmacological Sciences, 12, 31, 10.1016/S0928-0987(00)00177-9 Shapiro, 1997, Extraction of Hoechst 33342 from the cytoplasmic leaflet of the plasma membrane by P-glycoprotein, European Journal of Biochemistry, 250, 122, 10.1111/j.1432-1033.1997.00122.x Shapiro, 1998, The mechanism of ATP-dependent multidrug transport by P-glycoprotein, Acta Physiologica Scandinavica, 643, 227 Shen, 2010, Tetrandrine prevents acquired drug resistance of K562 cells through inhibition of mdr1 gene transcription, Journal of Cancer Research and Clinical Oncology, 136, 659, 10.1007/s00432-009-0704-3 Shen, 2006, (+/−)-3′-O, 4′-O-dicynnamoyl-cis-khellactone, a derivative of (+/−)-praeruptorin A, reverses P-glycoprotein mediated multidrug resistance in cancer cells, Bioorganic and Medicinal Chemistry, 14, 7138, 10.1016/j.bmc.2006.06.066 Sikic, 1993, Modulation of multidrug resistance: at the threshold, Journal of Clinical Oncology, 11, 1629, 10.1200/JCO.1993.11.9.1629 Sklar, 1988, Increased resistance to cis-diamminedichloroplatinum(II) in NIH 3T3 cells transformed by ras oncogenes, Cancer Research, 48, 793 Slovak, 1987, Cytogenetic alterations associated with the acquisition of doxorubicin resistance: possible significance of chromosome 7 alterations, Cancer Research, 47, 6646 Smit, 1993, Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease, Cell, 75, 451, 10.1016/0092-8674(93)90380-9 Sorrentino, 1992, Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1, Science, 257, 99, 10.1126/science.1352414 Sorrentino, 1995, Expression of retroviral vectors containing the human multidrug resistance 1 cDNA in hematopoietic cells of transplanted mice, Blood, 86, 491, 10.1182/blood.V86.2.491.bloodjournal862491 Suzuki, 2010, Selective regulation of multidrug resistance protein in vascular smooth muscle cells by the isoquinoline alkaloid coptisine, Biological & Pharmaceutical Bulletin, 33, 677, 10.1248/bpb.33.677 Takahashi, 2010, Effects of Acanthopanax senticosus HARMS extract on drug transport in human intestinal cell line Caco-2, Journal of Natural Medicines, 64, 55, 10.1007/s11418-009-0371-3 Takara, 2006, An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy, Current Pharmaceutical Design, 12, 273, 10.2174/138161206775201965 Tiwari, 2011, Revisiting the ABCs of multidrug resistance in cancer chemotherapy, Current Pharmaceutical Biotechnology, 12, 570, 10.2174/138920111795164048 Trock, 1997, Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance, Journal of the National Cancer Institute, 89, 917, 10.1093/jnci/89.13.917 Tsai, 2004, Hepatobiliary excretion of berberine, Drug Metabolism and Disposition, 32, 405, 10.1124/dmd.32.4.405 Tsai, 2004, Pharmacokinetics of baicalin in rats and its interactions with cyclosporin A, quinidine and SKF-525A: a microdialysis study, Planta Medica, 70, 1069, 10.1055/s-2004-832649 Tsai, 2003, Regulation of hepatobiliary excretion of sinomenine by P-glycoprotein in Sprague-Dawley rats, Life Sciences, 72, 2413, 10.1016/S0024-3205(03)00118-8 Tsuruo, 1989, Inhibition of multidrug-resistant human tumor growth in athymic mice by anti-P-glycoprotein monoclonal antibodies, Japanese Journal of Cancer Research: Gann, 80, 627, 10.1111/j.1349-7006.1989.tb01688.x Vaidyanathan, 2003, Cellular uptake and efflux of the tea flavonoid (−)epicatechin-3-gallate in the human intestinal cell line Caco-2, Journal of Pharmacology and Experimental Therapeutics, 307, 745, 10.1124/jpet.103.054296 van Helvoort, 1996, MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine, Cell, 87, 507, 10.1016/S0092-8674(00)81370-7 Verrelle, 1991, Clinical relevance of immunohistochemical detection of multidrug resistance P-glycoprotein in breast carcinoma, Journal of the National Cancer Institute, 83, 111, 10.1093/jnci/83.2.111 Vogel, 1959, Moderne Probleme der Humangenetik, Ergebnisse Innere Medizin Kinderheilkunde, 12, 52, 10.1007/978-3-642-94744-5_2 Volm, 1993, Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas, Cancer, 71, 3981, 10.1002/1097-0142(19930615)71:12<3981::AID-CNCR2820711231>3.0.CO;2-A Volm, 2004, Prediction of drug sensitivity and resistance of cancer by protein expression profiling, Cancer Genomics and Proteomics, 1, 157 Volm, 2002, Protein expression profiles indicative for drug resistance of non-small cell lung cancer, British Journal of Cancer, 87, 251, 10.1038/sj.bjc.6600463 Volm, 1991, Circumvention of multi-drug resistance in human kidney and kidney carcinoma in vitro, Cancer, 67, 2484, 10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I Volm, 1990, Overexpression of P-glycoprotein in rat hepatocellular carcinomas induced with N-nitrosomorpholine, Carcinogenesis, 11, 169, 10.1093/carcin/11.1.169 Wan, 2006, Gomisin A alters substrate interaction and reverses P-glycoprotein-mediated multidrug resistance in HepG2-DR cells, Biochemical Pharmacology, 72, 824, 10.1016/j.bcp.2006.06.036 Wang, 2004, Reversal of P-glycoprotein-mediated multidrug resistance by Alisol B 23-acetate, Biochemical Pharmacology, 68, 843, 10.1016/j.bcp.2004.05.021 Wang, 2002, Elevation of P-glycoprotein function by a catechin in green tea, Biochemical and Biophysical Research Communications, 297, 412, 10.1016/S0006-291X(02)02219-2 Wang, 2007, Chinese herbs of Shenghe Powder reverse multidrug resistance of gastric carcinoma SGC-7901, Integrative Cancer Therapies, 6, 400, 10.1177/1534735407309765 Wang, 2008, Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells, Yao Xue Xue Bao, 43, 461 Wang, 2010, Inhibition of tetramethylpyrazine on P-gp, MRP2, MRP3 and MRP5 in multidrug resistant human hepatocellular carcinoma cells, Oncology Reports, 23, 211 Wong, 2005, Pseudolaric acid B, a novel microtubule-destabilizing agent that circumvents multidrug resistance phenotype and exhibits antitumor activity in vivo, Clinical Cancer Research, 11, 6002, 10.1158/1078-0432.CCR-05-0209 Wu, 2003, Reversal of multidrug resistance in cancer cells by pyranocoumarins isolated from Radix Peucedani, European Journal of Pharmacology, 473, 9, 10.1016/S0014-2999(03)01946-0 Wu, 2010, Analysis of biliary excretion of icariin in rats, Journal of Agricultural and Food Chemistry, 58, 9905, 10.1021/jf101987j Xu, 2006, Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol, Cancer Letters, 243, 274, 10.1016/j.canlet.2005.11.031 Yang, 2008, Marked decrease of cyclosporin bioavailability caused by coadministration of ginkgo and onion in rats, Food and Chemical Toxicology, 44, 1572, 10.1016/j.fct.2006.04.008 Yao, 2009, Effect of liquorice decoction on rat intestinal P-glycoprotein, Nan Fang Yi Ke Da Xue Xue Bao, 29, 1571 Yeung, 2008, Identification of Ginkgo biloba as a novel activator of pregnane X receptor, Drug Metabolism and Disposition, 36, 2270, 10.1124/dmd.108.023499 Yokooji, 2010, Interaction of Rhei Rhizoma extract with cytochrome P450 3A and efflux transporters in rats, Pharmazie, 65, 367 Yu, 2010, Increased plasma exposures of five protoberberine alkaloids from Coptidis Rhizoma in streptozotocin-induced diabetic rats: is P-GP involved?, Planta Medica, 76, 876, 10.1055/s-0029-1240815 Yu, 2007, Transport of cryptotanshinone, a major active triterpenoid in Salvia miltiorrhiza Bunge widely used in the treatment of stroke and Alzheimer's disease, across the blood–brain barrier, Current Drug Metabolism, 8, 365, 10.2174/138920007780655441 Yu, 2007, Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge, Current Drug Metabolism, 8, 325, 10.2174/138920007780655450 Yu, 2007, Role of ATP-binding cassette drug transporters in the intestinal absorption of tanshinone IIB, one of the major active diterpenoids from the root of Salvia miltiorrhiza, Xenobiotica, 37, 375, 10.1080/00498250701230559 Zhang, 2007, In-vivo and in-vitro studies on the effect of Huang-Lian-Jie-Du-Tang on nimodipine transport across rat blood–brain barrier, The Journal of Pharmacy and Pharmacology, 59, 1733, 10.1211/jpp.59.12.0017 Zhang, 2006, A mechanistic study of the intestinal absorption of cryptotanshinone, the major active constituent of Salvia miltiorrhiza, The Journal of Pharmacology and Experimental Therapeutics, 317, 1285, 10.1124/jpet.105.100701 Zhang, 2010, 20(S)-ginsenoside Rh2 noncompetitively inhibits P-glycoprotein in vitro and in vivo: a case for herb–drug interactions, Drug Metabolism and Disposition, 38, 2179, 10.1124/dmd.110.034793 Zhang, 2009, Long-term effects of Panax ginseng on disposition of fexofenadine in rats in vivo, The American Journal of Chinese Medicine, 37, 657, 10.1142/S0192415X09007144 Zhou, 1995, Homoharringtonine: an effective new natural product in cancer chemotherapy, Bulletin du Cancer, 82, 987 Zhou, 2007, Involvement of P-glycoprotein and multidrug resistance associated protein 1 in the transport of tanshinone IIB, a primary active diterpenoid quinone from the roots of Salvia miltiorrhiza, across the blood–brain barrier, Drug Metabolism Letters, 1, 205, 10.2174/187231207781369807 Zhu, 2001, Study of tea polyphenol as a reversal agent for carcinoma cell lines’ multidrug resistance (study of TP as a MDR reversal agent), Nuclear Medicine and Biology, 28, 735, 10.1016/S0969-8051(00)90202-6 Zhu, 2006, Transport mechanism of danshensu across Caco-2 monolayer model, Zhongguo Zhong Yao Za Zhi, 31, 1517 Zou, 2010, Mechanism of Chinese herbal compound Zilongjin for antagonizing multi-drug resistance of tumor cells, Zhongguo Zhong Xi Yi Jie He Za Zhi, 30, 601